Invention Grant
- Patent Title: HEV vaccine
-
Application No.: US16302891Application Date: 2017-05-24
-
Publication No.: US10512685B2Publication Date: 2019-12-24
- Inventor: Paul Vermeij , Ad Groof De , Carla Christina Schrier , Wannes Vogels
- Applicant: Intervet Inc.
- Applicant Address: US NJ Madison
- Assignee: Intervet Inc.
- Current Assignee: Intervet Inc.
- Current Assignee Address: US NJ Madison
- Priority: EP16171324 20160525
- International Application: PCT/EP2017/062638 WO 20170524
- International Announcement: WO2017/202973 WO 20171130
- Main IPC: C07K14/005
- IPC: C07K14/005 ; C07K14/08 ; A61K39/00 ; A61K39/29 ; C12Q1/70 ; A61K39/12 ; A61P31/14 ; A61K39/39
Abstract:
The present invention relates to a vaccine comprising Open Reading Frame 2 (ORF2) protein of Swine Hepatitis E virus (HEV) and a pharmaceutically acceptable carrier, for use in the protection of anti-HEV MDA-positive piglets against HEV fecal shedding.
Public/Granted literature
- US20190151442A1 HEV VACCINE Public/Granted day:2019-05-23
Information query
